Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
NICE Increases Options For Hyperkalemia Patients In England
Vifor’s Veltassa & AstraZeneca’s Lokelma Get Green Light
Dec 17 2019
•
By
Ian Schofield
NICE has OKd two treatments for high potassium blood levels • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from United Kingdom
More from Europe